目次

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 06: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global beta lactam and beta lactamase inhibitors market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global beta lactam and beta lactamase inhibitors market 2018 - 2022 ($ billion)
4.2 Route of Administration Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
4.3 Drug Class Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Drug Class Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Route of Administration
6.1 Market segments
Exhibit 30: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibit 31: Data Table on Route of Administration - Market share 2023-2028 (%)
6.2 Comparison by Route of Administration
Exhibit 32: Chart on Comparison by Route of Administration
Exhibit 33: Data Table on Comparison by Route of Administration
6.3 Oral - Market size and forecast 2023-2028
Exhibit 34: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Oral - Year-over-year growth 2023-2028 (%)
6.4 Intravenous - Market size and forecast 2023-2028
Exhibit 38: Chart on Intravenous - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Intravenous - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Intravenous - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Intravenous - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Route of Administration
Exhibit 46: Market opportunity by Route of Administration ($ billion)
Exhibit 47: Data Table on Market opportunity by Route of Administration ($ billion)

7 Market Segmentation by Drug Class
7.1 Market segments
Exhibit 48: Chart on Drug Class - Market share 2023-2028 (%)
Exhibit 49: Data Table on Drug Class - Market share 2023-2028 (%)
7.2 Comparison by Drug Class
Exhibit 50: Chart on Comparison by Drug Class
Exhibit 51: Data Table on Comparison by Drug Class
7.3 Cephalosporins - Market size and forecast 2023-2028
Exhibit 52: Chart on Cephalosporins - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Cephalosporins - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Cephalosporins - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Cephalosporins - Year-over-year growth 2023-2028 (%)
7.4 Penicillins - Market size and forecast 2023-2028
Exhibit 56: Chart on Penicillins - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Penicillins - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Penicillins - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Penicillins - Year-over-year growth 2023-2028 (%)
7.5 Carbapenems - Market size and forecast 2023-2028
Exhibit 60: Chart on Carbapenems - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Carbapenems - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Carbapenems - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Carbapenems - Year-over-year growth 2023-2028 (%)
7.6 Monobactams - Market size and forecast 2023-2028
Exhibit 64: Chart on Monobactams - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Data Table on Monobactams - Market size and forecast 2023-2028 ($ billion)
Exhibit 66: Chart on Monobactams - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Monobactams - Year-over-year growth 2023-2028 (%)
7.7 Combination - Market size and forecast 2023-2028
Exhibit 68: Chart on Combination - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Data Table on Combination - Market size and forecast 2023-2028 ($ billion)
Exhibit 70: Chart on Combination - Year-over-year growth 2023-2028 (%)
Exhibit 71: Data Table on Combination - Year-over-year growth 2023-2028 (%)
7.8 Market opportunity by Drug Class
Exhibit 72: Market opportunity by Drug Class ($ billion)
Exhibit 73: Data Table on Market opportunity by Drug Class ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 75: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 77: Chart on Geographic comparison
Exhibit 78: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 103: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 India - Market size and forecast 2023-2028
Exhibit 107: Chart on India - Market size and forecast 2023-2028 ($ billion)
Exhibit 108: Data Table on India - Market size and forecast 2023-2028 ($ billion)
Exhibit 109: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on India - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Exhibit 111: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 112: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 113: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 114: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 115: Market opportunity By Geographical Landscape ($ billion)
Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 117: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 119: Overview on factors of disruption
11.4 Industry risks
Exhibit 120: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 121: Vendors covered
12.2 Market positioning of vendors
Exhibit 122: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 123: Abbott Laboratories - Overview
Exhibit 124: Abbott Laboratories - Business segments
Exhibit 125: Abbott Laboratories - Key offerings
Exhibit 126: Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
Exhibit 127: AbbVie Inc. - Overview
Exhibit 128: AbbVie Inc. - Product / Service
Exhibit 129: AbbVie Inc. - Key news
Exhibit 130: AbbVie Inc. - Key offerings
12.5 Alkem Laboratories Ltd.
Exhibit 131: Alkem Laboratories Ltd. - Overview
Exhibit 132: Alkem Laboratories Ltd. - Business segments
Exhibit 133: Alkem Laboratories Ltd. - Key news
Exhibit 134: Alkem Laboratories Ltd. - Key offerings
Exhibit 135: Alkem Laboratories Ltd. - Segment focus
12.6 Astellas Pharma Inc.
Exhibit 136: Astellas Pharma Inc. - Overview
Exhibit 137: Astellas Pharma Inc. - Product / Service
Exhibit 138: Astellas Pharma Inc. - Key news
Exhibit 139: Astellas Pharma Inc. - Key offerings
12.7 Cipla Ltd.
Exhibit 140: Cipla Ltd. - Overview
Exhibit 141: Cipla Ltd. - Business segments
Exhibit 142: Cipla Ltd. - Key news
Exhibit 143: Cipla Ltd. - Key offerings
Exhibit 144: Cipla Ltd. - Segment focus
12.8 F. Hoffmann La Roche Ltd.
Exhibit 145: F. Hoffmann La Roche Ltd. - Overview
Exhibit 146: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 147: F. Hoffmann La Roche Ltd. - Key news
Exhibit 148: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 149: F. Hoffmann La Roche Ltd. - Segment focus
12.9 GlaxoSmithKline Plc
Exhibit 150: GlaxoSmithKline Plc - Overview
Exhibit 151: GlaxoSmithKline Plc - Business segments
Exhibit 152: GlaxoSmithKline Plc - Key news
Exhibit 153: GlaxoSmithKline Plc - Key offerings
Exhibit 154: GlaxoSmithKline Plc - Segment focus
12.10 MedPlus Health Services Ltd.
Exhibit 155: MedPlus Health Services Ltd. - Overview
Exhibit 156: MedPlus Health Services Ltd. - Product / Service
Exhibit 157: MedPlus Health Services Ltd. - Key offerings
12.11 Meiji Holdings Co. Ltd.
Exhibit 158: Meiji Holdings Co. Ltd. - Overview
Exhibit 159: Meiji Holdings Co. Ltd. - Business segments
Exhibit 160: Meiji Holdings Co. Ltd. - Key news
Exhibit 161: Meiji Holdings Co. Ltd. - Key offerings
Exhibit 162: Meiji Holdings Co. Ltd. - Segment focus
12.12 Merck KGaA
Exhibit 163: Merck KGaA - Overview
Exhibit 164: Merck KGaA - Business segments
Exhibit 165: Merck KGaA - Key news
Exhibit 166: Merck KGaA - Key offerings
Exhibit 167: Merck KGaA - Segment focus
12.13 Novartis AG
Exhibit 168: Novartis AG - Overview
Exhibit 169: Novartis AG - Business segments
Exhibit 170: Novartis AG - Key news
Exhibit 171: Novartis AG - Key offerings
Exhibit 172: Novartis AG - Segment focus
12.14 Pfizer Inc.
Exhibit 173: Pfizer Inc. - Overview
Exhibit 174: Pfizer Inc. - Product / Service
Exhibit 175: Pfizer Inc. - Key news
Exhibit 176: Pfizer Inc. - Key offerings
12.15 Sandoz AG
Exhibit 177: Sandoz AG - Overview
Exhibit 178: Sandoz AG - Product / Service
Exhibit 179: Sandoz AG - Key news
Exhibit 180: Sandoz AG - Key offerings
12.16 Sanofi SA
Exhibit 181: Sanofi SA - Overview
Exhibit 182: Sanofi SA - Business segments
Exhibit 183: Sanofi SA - Key news
Exhibit 184: Sanofi SA - Key offerings
Exhibit 185: Sanofi SA - Segment focus
12.17 Spero Therapeutics
Exhibit 186: Spero Therapeutics - Overview
Exhibit 187: Spero Therapeutics - Product / Service
Exhibit 188: Spero Therapeutics - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 189: Inclusions checklist
Exhibit 190: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 191: Currency conversion rates for US$
13.4 Research methodology
Exhibit 192: Research methodology
Exhibit 193: Validation techniques employed for market sizing
Exhibit 194: Information sources
13.5 List of abbreviations
Exhibit 195: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global beta lactam and beta lactamase inhibitors market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Drug Class Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits31: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Route of Administration
Exhibits33: Data Table on Comparison by Route of Administration
Exhibits34: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Intravenous - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Intravenous - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Intravenous - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Intravenous - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Route of Administration ($ billion)
Exhibits47: Data Table on Market opportunity by Route of Administration ($ billion)
Exhibits48: Chart on Drug Class - Market share 2023-2028 (%)
Exhibits49: Data Table on Drug Class - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Drug Class
Exhibits51: Data Table on Comparison by Drug Class
Exhibits52: Chart on Cephalosporins - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Cephalosporins - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Cephalosporins - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Cephalosporins - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Penicillins - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Penicillins - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Penicillins - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Penicillins - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Carbapenems - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Carbapenems - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Carbapenems - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Carbapenems - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Monobactams - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Data Table on Monobactams - Market size and forecast 2023-2028 ($ billion)
Exhibits66: Chart on Monobactams - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Monobactams - Year-over-year growth 2023-2028 (%)
Exhibits68: Chart on Combination - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Data Table on Combination - Market size and forecast 2023-2028 ($ billion)
Exhibits70: Chart on Combination - Year-over-year growth 2023-2028 (%)
Exhibits71: Data Table on Combination - Year-over-year growth 2023-2028 (%)
Exhibits72: Market opportunity by Drug Class ($ billion)
Exhibits73: Data Table on Market opportunity by Drug Class ($ billion)
Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits75: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits77: Chart on Geographic comparison
Exhibits78: Data Table on Geographic comparison
Exhibits79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on India - Market size and forecast 2023-2028 ($ billion)
Exhibits108: Data Table on India - Market size and forecast 2023-2028 ($ billion)
Exhibits109: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits111: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits112: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits113: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits114: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits115: Market opportunity By Geographical Landscape ($ billion)
Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits117: Impact of drivers and challenges in 2023 and 2028
Exhibits118: Overview on Criticality of inputs and Factors of differentiation
Exhibits119: Overview on factors of disruption
Exhibits120: Impact of key risks on business
Exhibits121: Vendors covered
Exhibits122: Matrix on vendor position and classification
Exhibits123: Abbott Laboratories - Overview
Exhibits124: Abbott Laboratories - Business segments
Exhibits125: Abbott Laboratories - Key offerings
Exhibits126: Abbott Laboratories - Segment focus
Exhibits127: AbbVie Inc. - Overview
Exhibits128: AbbVie Inc. - Product / Service
Exhibits129: AbbVie Inc. - Key news
Exhibits130: AbbVie Inc. - Key offerings
Exhibits131: Alkem Laboratories Ltd. - Overview
Exhibits132: Alkem Laboratories Ltd. - Business segments
Exhibits133: Alkem Laboratories Ltd. - Key news
Exhibits134: Alkem Laboratories Ltd. - Key offerings
Exhibits135: Alkem Laboratories Ltd. - Segment focus
Exhibits136: Astellas Pharma Inc. - Overview
Exhibits137: Astellas Pharma Inc. - Product / Service
Exhibits138: Astellas Pharma Inc. - Key news
Exhibits139: Astellas Pharma Inc. - Key offerings
Exhibits140: Cipla Ltd. - Overview
Exhibits141: Cipla Ltd. - Business segments
Exhibits142: Cipla Ltd. - Key news
Exhibits143: Cipla Ltd. - Key offerings
Exhibits144: Cipla Ltd. - Segment focus
Exhibits145: F. Hoffmann La Roche Ltd. - Overview
Exhibits146: F. Hoffmann La Roche Ltd. - Business segments
Exhibits147: F. Hoffmann La Roche Ltd. - Key news
Exhibits148: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits149: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits150: GlaxoSmithKline Plc - Overview
Exhibits151: GlaxoSmithKline Plc - Business segments
Exhibits152: GlaxoSmithKline Plc - Key news
Exhibits153: GlaxoSmithKline Plc - Key offerings
Exhibits154: GlaxoSmithKline Plc - Segment focus
Exhibits155: MedPlus Health Services Ltd. - Overview
Exhibits156: MedPlus Health Services Ltd. - Product / Service
Exhibits157: MedPlus Health Services Ltd. - Key offerings
Exhibits158: Meiji Holdings Co. Ltd. - Overview
Exhibits159: Meiji Holdings Co. Ltd. - Business segments
Exhibits160: Meiji Holdings Co. Ltd. - Key news
Exhibits161: Meiji Holdings Co. Ltd. - Key offerings
Exhibits162: Meiji Holdings Co. Ltd. - Segment focus
Exhibits163: Merck KGaA - Overview
Exhibits164: Merck KGaA - Business segments
Exhibits165: Merck KGaA - Key news
Exhibits166: Merck KGaA - Key offerings
Exhibits167: Merck KGaA - Segment focus
Exhibits168: Novartis AG - Overview
Exhibits169: Novartis AG - Business segments
Exhibits170: Novartis AG - Key news
Exhibits171: Novartis AG - Key offerings
Exhibits172: Novartis AG - Segment focus
Exhibits173: Pfizer Inc. - Overview
Exhibits174: Pfizer Inc. - Product / Service
Exhibits175: Pfizer Inc. - Key news
Exhibits176: Pfizer Inc. - Key offerings
Exhibits177: Sandoz AG - Overview
Exhibits178: Sandoz AG - Product / Service
Exhibits179: Sandoz AG - Key news
Exhibits180: Sandoz AG - Key offerings
Exhibits181: Sanofi SA - Overview
Exhibits182: Sanofi SA - Business segments
Exhibits183: Sanofi SA - Key news
Exhibits184: Sanofi SA - Key offerings
Exhibits185: Sanofi SA - Segment focus
Exhibits186: Spero Therapeutics - Overview
Exhibits187: Spero Therapeutics - Product / Service
Exhibits188: Spero Therapeutics - Key offerings
Exhibits189: Inclusions checklist
Exhibits190: Exclusions checklist
Exhibits191: Currency conversion rates for US$
Exhibits192: Research methodology
Exhibits193: Validation techniques employed for market sizing
Exhibits194: Information sources
Exhibits195: List of abbreviations